TherapeuticsMD Ownership | Who Owns TherapeuticsMD?


OverviewForecastRevenueFinancialsChart

TherapeuticsMD Ownership Summary


TherapeuticsMD is owned by 28.54% institutional investors, 1.55% insiders, and 69.91% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.30% of TXMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTherapeuticsMD28.54%1.55%69.91%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp1.19M10.30%$1.28M
Clearline capital lp635.22K5.49%$682.86K
Vanguard group376.83K3.26%$399.44K
Tejara capital344.20K2.97%$370.02K
Adar1 capital management209.21K1.81%$224.90K
Morgan stanley130.57K1.13%$140.37K
Blackrock125.15K1.09%$201.50K
Blackrock funding, inc. /de116.13K1.00%$124.84K
Geode capital management109.08K0.94%$115.66K
Renaissance35.50K0.31%$38.16K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tejara capital344.20K0.19%$370.02K
Clearline capital lp635.22K0.03%$682.86K
Adar1 capital management209.21K0.02%$224.90K
Rubric capital management lp1.19M0.01%$1.28M
Two sigma securities11.97K0.00%$12.87K
Bridgeway capital management34.00K0.00%$36.04K
J. goldman & co lp13.56K0.00%$14.58K
Renaissance35.50K0.00%$38.16K
Tower research capital llc (trc)2.73K0.00%$2.94K
Guardian wealth management---

Top Buyers

HolderShares% AssetsChange
Renaissance35.50K0.00%20.60K
Two sigma securities11.97K0.00%1.53K
Group one trading1.14K-1.14K
Bank of america corp /de/487.00-87.00
Barclays44.00-44.00

Top Sellers

HolderShares% AssetsChange
Clear harbor asset management---25.81K
Prosperity consulting group---24.50K
Ameriprise financial---22.47K
Gabelli funds---12.00K
Blackrock125.15K--10.63K

New Positions

HolderShares% AssetsChangeValue
Group one trading1.14K-1.14K$976.00K
Barclays44.00-44.00$47.00
Wealth watch advisors22.00-22.00$24.00

Sold Out

HolderChange
Aspire private capital-1.00
Sterling capital management-1.00
Northwestern mutual wealth management-2.00
Guardian wealth management-2.00
Qube research-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202539-4.88%3,303,7511.48%283.61%6-45.45%1025.00%
Jun 30, 202540-2.44%3,254,871-2.65%283.36%10-9.09%912.50%
Mar 31, 2025402.56%3,343,569-5.25%283.09%11-860.00%
Dec 31, 202424-31.43%1,302,899-61.44%111.32%8-3-25.00%
Sep 30, 202434-8.11%3,378,926-0.87%293.35%8-4-60.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF249.66K2.16%-
Vanguard Total Stock Mkt Idx Inv244.32K2.11%-5.34K
Vanguard Institutional Extnd Mkt Idx Tr83.97K0.73%-38.26K
Fidelity Extended Market Index63.62K0.55%-448.00
Bridgeway Ultra-Small Company Market34.00K0.29%-
BlackRock Extended Equity Market K16.29K0.14%-7.00
Extended Equity Market Fund K15.80K0.14%-315.00
Fidelity Series Total Market Index15.32K0.13%-
Fidelity Total Market Index14.84K0.13%-
Spartan Extended Market Index Pool F10.21K0.09%448.00

Recent Insider Transactions


DateNameRoleActivityValue
Apr 14, 2025Thompson Tommy G-Buy$325.59
Apr 14, 2025Walker Marlan D Chief Executive OfficerBuy$489.27
Apr 09, 2025Walker Marlan D Chief Executive OfficerBuy$993.66
Apr 10, 2025Walker Marlan D Chief Executive OfficerBuy$1.00K
Aug 22, 2024Collins Cooper C.-Buy$7.10K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q24-
2025 Q1--
2024 Q32-
2023 Q4-2

TXMD Ownership FAQ


Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 28.54%, followed by 1.55% insiders and 69.91% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which TherapeuticsMD exceeds.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.30%), Clearline capital lp (635.22K shares, 5.49%), and Vanguard group (376.83K shares, 3.26%). Together, they hold 19.04% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 344.2K TherapeuticsMD shares, valued at 370.02K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools